IN2003MU00504A - - Google Patents

Info

Publication number
IN2003MU00504A
IN2003MU00504A IN504MU2003A IN2003MU00504A IN 2003MU00504 A IN2003MU00504 A IN 2003MU00504A IN 504MU2003 A IN504MU2003 A IN 504MU2003A IN 2003MU00504 A IN2003MU00504 A IN 2003MU00504A
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Sampad Bhattacharya
Sridhar Gummudavelli
Mayank Joshi
Original Assignee
Alembic Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alembic Ltd filed Critical Alembic Ltd
Priority to IN504MU2003 priority Critical patent/IN2003MU00504A/en
Priority to US10/563,631 priority patent/US20070110808A1/en
Priority to PCT/IN2004/000133 priority patent/WO2004108117A2/en
Priority to AT04770652T priority patent/ATE358472T1/de
Priority to ES04770652T priority patent/ES2286676T3/es
Priority to DE602004005709T priority patent/DE602004005709T2/de
Priority to EP04770652A priority patent/EP1633330B1/en
Publication of IN2003MU00504A publication Critical patent/IN2003MU00504A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IN504MU2003 2003-06-05 2003-06-05 IN2003MU00504A (cs)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IN504MU2003 IN2003MU00504A (cs) 2003-06-05 2003-06-05
US10/563,631 US20070110808A1 (en) 2003-06-05 2004-05-14 Extended release osmo-microsealed formulation
PCT/IN2004/000133 WO2004108117A2 (en) 2003-06-05 2004-05-14 Extended release osmo-microsealed formulation comprising venlafaxine
AT04770652T ATE358472T1 (de) 2003-06-05 2004-05-14 Osmo-mikroverschlossene zubereitung mit verlängerter freisetzung von venlafaxine
ES04770652T ES2286676T3 (es) 2003-06-05 2004-05-14 Formulacion osmomicrosellada de liberacion prolongada.
DE602004005709T DE602004005709T2 (de) 2003-06-05 2004-05-14 Osmo-mikroverschlossene zubereitung mit verlängerter freisetzung von venlafaxine
EP04770652A EP1633330B1 (en) 2003-06-05 2004-05-14 Extended release osmo-microsealed formulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN504MU2003 IN2003MU00504A (cs) 2003-06-05 2003-06-05

Publications (1)

Publication Number Publication Date
IN2003MU00504A true IN2003MU00504A (cs) 2005-05-13

Family

ID=33495860

Family Applications (1)

Application Number Title Priority Date Filing Date
IN504MU2003 IN2003MU00504A (cs) 2003-06-05 2003-06-05

Country Status (7)

Country Link
US (1) US20070110808A1 (cs)
EP (1) EP1633330B1 (cs)
AT (1) ATE358472T1 (cs)
DE (1) DE602004005709T2 (cs)
ES (1) ES2286676T3 (cs)
IN (1) IN2003MU00504A (cs)
WO (1) WO2004108117A2 (cs)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
CA2389235C (en) 1999-10-29 2007-07-17 Euro-Celtique, S.A. Controlled release hydrocodone formulations
KR100968128B1 (ko) 2000-10-30 2010-07-06 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
CN101111245A (zh) 2005-01-27 2008-01-23 阿雷姆贝克有限公司 左乙拉西坦延长释放制剂
EP2502621A1 (en) 2005-06-27 2012-09-26 Valeant International (Barbados) SRL Crystalline forms of bupropion HBr
ZA200802602B (en) * 2005-08-24 2009-10-28 Rubicon Res Pvt Ltd Controlled release formulation
MX2008012299A (es) * 2006-03-31 2008-11-18 Rubicon Res Private Ltd Tabletas de desintegracion oral.
GB0610570D0 (en) * 2006-05-27 2006-07-05 Pliva Istrazivanje I Razvoj D Novel formulation
US8445018B2 (en) 2006-09-15 2013-05-21 Cima Labs Inc. Abuse resistant drug formulation
US20100092564A1 (en) * 2006-12-21 2010-04-15 Jae Han Park Composition of and Method for Preparing Orally Disintegrating Tablets
US20080245273A1 (en) * 2007-04-05 2008-10-09 Jouko Vyorkka Hydrophobic coatings
WO2009155488A2 (en) * 2008-06-19 2009-12-23 Segrub, Llc Novel oxalate salt and crystal of o-desmethylvenlafaxine
CA2749933A1 (en) * 2009-02-04 2010-08-12 Supernus Pharmaceuticals, Inc. Formulations of desvenlafaxine
JP5055397B2 (ja) * 2010-03-10 2012-10-24 株式会社ユニックスジャパン 歯科用成形体、及び歯科用樹脂材料
MX2012013023A (es) * 2010-05-11 2012-12-17 Cima Labs Inc Formas de dosificacion de liberacion prolongada resistentes ala alcohol y que comprenden venlafaxina.
MX2012012991A (es) 2010-05-11 2012-11-30 Cima Labs Inc Formas de dosificacion oral de liberacion prolongada resistentes al alcohol y que contienen metoprolol.
US20150275167A1 (en) * 2014-03-28 2015-10-01 Corning Incorporated Composition and method for cell culture sustained release
CN106236739B (zh) * 2016-07-27 2019-06-07 上海宣泰生物科技有限公司 含有叶黄素/叶黄素酯的组合物及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274171B1 (en) * 1996-03-25 2001-08-14 American Home Products Corporation Extended release formulation of venlafaxine hydrochloride
PE57198A1 (es) * 1996-03-25 1998-10-10 American Home Prod Formula de liberacion prolongada
CA2216215A1 (en) * 1997-04-05 1998-10-05 Isa Odidi Controlled release formulations using intelligent polymers having opposing wettability characteristics of hydrophobicity and hydrophilicity
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6572890B2 (en) * 2000-01-13 2003-06-03 Osmotica Corp. Osmotic device containing venlafaxine and an anti-psychotic agent
US6352721B1 (en) * 2000-01-14 2002-03-05 Osmotica Corp. Combined diffusion/osmotic pumping drug delivery system
US20030091634A1 (en) * 2001-09-14 2003-05-15 Pawan Seth Delayed release tablet of venlafaxin

Also Published As

Publication number Publication date
ES2286676T3 (es) 2007-12-01
EP1633330A2 (en) 2006-03-15
US20070110808A1 (en) 2007-05-17
ATE358472T1 (de) 2007-04-15
DE602004005709T2 (de) 2008-01-24
EP1633330B1 (en) 2007-04-04
DE602004005709D1 (de) 2007-05-16
WO2004108117A3 (en) 2005-09-15
WO2004108117A2 (en) 2004-12-16

Similar Documents

Publication Publication Date Title
FR21C1056I1 (cs)
BE2013C075I2 (cs)
BE2013C069I2 (cs)
BE2013C067I2 (cs)
BE2013C038I2 (cs)
BE2013C036I2 (cs)
BE2011C030I2 (cs)
JP2004007576A5 (cs)
BE2013C034I2 (cs)
IN2008CH00415A (cs)
BE2012C053I2 (cs)
JP2004165141A5 (cs)
IN2003MU00504A (cs)
JP2004091778A5 (cs)
JP2004209084A5 (cs)
JP2004069679A5 (cs)
JP2003215712A5 (cs)
JP2003280242A5 (cs)
JP2003219283A5 (cs)
JP2004140351A5 (cs)
JP2004015055A5 (cs)
FR2833252A3 (cs)
JP2004091048A5 (cs)
AU2002322913A1 (cs)
AU2002321535A1 (cs)